These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11345612)

  • 1. [Secondary prevention of opportunistic infections in HIV-infected patients].
    Asencio Marchante R; Lissen Otero E
    Rev Clin Esp; 2001 Feb; 201(2):88-9. PubMed ID: 11345612
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV: opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2003 Jun; (9):795-816. PubMed ID: 15366175
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV: prevention of opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2005 Jun; (13):834-53. PubMed ID: 16135281
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV: prevention of opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2003 Dec; (10):809-30. PubMed ID: 15555123
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing opportunistic infections.
    Cheng B
    PI Perspect; 1995 May; (no 16):14-5. PubMed ID: 11362422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding prophylactic therapy for HIV infections.
    Anastasi JK; Rivera J
    Am J Nurs; 1994 Feb; 94(2):36-41; quiz 42. PubMed ID: 8304396
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on opportunistic infections.
    Proj Inf Perspect; 1997 Nov; (23):16-7. PubMed ID: 11365373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of prophylaxis for opportunistic infections in HIV-infected patients.
    Decker CF; Masur H
    AIDS; 1994 Jan; 8(1):11-20. PubMed ID: 8011221
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
    Hardy WD
    AIDS Clin Rev; 1991; ():145-80. PubMed ID: 1651099
    [No Abstract]   [Full Text] [Related]  

  • 10. The cost-effectiveness of preventing AIDS-related opportunistic infections.
    Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
    JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC).
    Schouten JT; Whittemore S
    STEP Perspect; 1996; 8(3):5-6. PubMed ID: 11364267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of common HIV-associated opportunistic complications.
    Carmichael C
    Prim Care; 1997 Sep; 24(3):561-74. PubMed ID: 9271692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Deschênes J; Phillips P; Turgeon F; Aoki FY; Toma E; Miller M; Duperval R; Lemieux C; Schlech WF
    J Infect Dis; 1998 Jan; 177(1):252-5. PubMed ID: 9419201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic infections studies update.
    Walker MJ
    NIAID AIDS Agenda; 1995; ():6-7. PubMed ID: 11362449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of opportunistic infections in HIV/AIDS.
    Goldschmidt RH
    Am Fam Physician; 1997 Sep; 56(4):1039-40. PubMed ID: 9310055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of HIV-associated opportunistic infections].
    Gazzard BG
    Internist (Berl); 1994 Oct; 35(10):901-5. PubMed ID: 8002224
    [No Abstract]   [Full Text] [Related]  

  • 17. Opportunistic infections update.
    PI Perspect; 1996 Sep; (No 19):15-6. PubMed ID: 11363899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
    Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of patients infected by the human immunodeficiency virus (HIV). Report of an expert group].
    Delfraissy JF;
    Rev Pneumol Clin; 2002 Dec; 58(6 Pt 1):312-40. PubMed ID: 12545131
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of opportunistic infections in HIV seropositive patients. Prevention of parasitic infections].
    Casassus P; Padrazzi B; Lhote F; Jarrousse B
    Presse Med; 1997 Mar; 26(7):334-9. PubMed ID: 9122147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.